HomeInsightsPB

Bliss Gvs Pharma Ltd PB Ratio

Bliss Gvs Pharma Ltd PB Ratio

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

14.0 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

PB

1.3

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Bliss GVS Pharma Ltd is 1.3 as of 07 Nov 24.
  • The P/B Ratio of Bliss GVS Pharma Ltd changed from 1 on March 2022 to 1.2 on March 2024 . This represents a CAGR of 6.27% over 3 years. .

Historical P/B Ratio of Bliss GVS Pharma Ltd

No data available

Company Fundamentals for Bliss GVS Pharma Ltd

Market Cap

1,332 Cr

EPS

8.0

P/E Ratio (TTM) *

15.8

P/B Ratio (TTM) *

1.3

Day’s High *

131.15

Day’s Low

126.25

DTE *

0.1

ROE *

8.3

52 Week High

148.95

52 Week Low

92.25

ROCE *

12.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024126.55
06 Nov 2024129.2
05 Nov 2024123.5
04 Nov 2024124.25
01 Nov 2024126.9
31 Oct 2024123.4
30 Oct 2024125.95
29 Oct 2024123.65
28 Oct 2024117.95
25 Oct 2024108.65

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Bliss GVS Pharma Ltd11,332
Sun Pharmaceuticals Industries Ltd984,29,841
Divis Laboratories Ltd5071,58,179
Cipla Ltd3601,27,063
Mankind Pharma Ltd2691,09,234
Dr Reddys Laboratories Ltd3221,07,398

Key Valuation Metric of Bliss GVS Pharma Ltd

Share Price

₹127

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

18 Oct 202410:48

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

04 Oct 202418:37

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 202411:35

News

Bliss GVS Pharma to convene AGM

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will b...

Read more

04 May 202416:04

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

03 May 202410:36

News

Bliss GVS Pharma announces board meeting date

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 202...

Read more

26 Apr 202411:02

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Bliss GVS Pharma Ltd

What is the PB ratio of Bliss GVS Pharma Ltd?

The current PB ratio of Bliss GVS Pharma Ltd is 1.32. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Bliss GVS Pharma Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Bliss GVS Pharma Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Bliss GVS Pharma Ltd calculated?

The PB ratio of Bliss GVS Pharma Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Bliss GVS Pharma Ltd?

A high PB ratio suggests that Bliss GVS Pharma Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Bliss GVS Pharma Ltd?

A low PB ratio of Bliss GVS Pharma Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Bliss GVS Pharma Ltd PB Ratio change over time?

Yes, the PB ratio of Bliss GVS Pharma Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*